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INTRODUCTION
Objects and relationships between objects are of interest within many Sciences and many other human activities. From a mathematical point of view, Category theory studies these in an abstract manner via structures and relationships between them such as via the use of sets and functions. While from a Computer Science point of view, Graph theory studies these using the concept of a graph, G, that is defined to be composed of two sets; a set of nodes (also called vertices) V , and a set of edges, E. Relating these two perspectives may be achieved by noticing that an edge may be present or absent between nodes in a graph and that from a mathematical point of view, this is a binary relation. Further abstractions are also possible. This now leads to two problems of interest: (i) relating objects and relationships to a suitable representation (such as nodes and edges) and (ii) analyzing the representation in order make hypotheses about the original objects of study. The concrete objectives of this study are to investigate three publicly available biological 
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(c) Intracellular Application FIGURE 2. An interaction graph is constructed by adding: i) each unique molecule (from the two input lists) as a node, and ii) an edge whenever an interaction exists in at least one of the databases of interest, which are not stable in time. Two very different list construction approaches using mass spectrometry provide context specific (non-global) interaction graphs. networks containing protein-protein interaction information in order to determine if such information aids the analysis of two specific biological problems, namely: (i) inter-and (ii) intra-cellular analysis (See Fig. 1 ). There are many avenues of investigation and there is a long history [1] [2] [3] [4] [5] [6] [7] . Specific interactions between two or more type of cells play important roles in the pathology of human disease. For example, in multiple sclerosis T-cells from blood interact with endothelial cells in the brain that can subsequently lead to brain damage. The interactions between two (or more) types of cells consist of protein-protein interactions on the cells and are referred to as intercellular interactions. Identifying these specific interacting proteins on the two cells (i.e. T-cells and brain cells) using proteomics and interactomics methods, whose disruption would inhibit the cell-cell interactions (using specific drugs), is an attractive target for the therapy of multiple sclerosis [6] . In addition, changes in protein-protein interactions within a single cell (intracellular interactions), as a result of a change in pathological state, are also considered an attractive target for a number of human diseases. For example, identifying specific changes in protein interactions in a cancer cell as a result of benignto-malignant transformation and finding which one would destroy the network (and hence the malignant cells) is of therapeutic significance. Proteomics and other 'omics methods generate an overwhelming list of molecules from the analysis of tissues, cell lines etc. that quickly becomes unmanageable. For example, in order to validate a list of proteins, a costly and time consuming process is performed in the laboratory. One reductionist approach often undertaken is to select a couple of the molecules for further evaluation. However, this relies on literature and well studied molecules, with a significant portion of disease-implicated molecules being overlooked. Interactomics links novel molecules with potentially disease related (e.g. cancer) molecules and pathways, hence is one possible approach upon which a methodology for prioritization of targets may be constructed.
RESULTS
This paper investigates three public data sets: i) KEGG [8] , ii) Reactome [9] , and iii) GeneRIF http://www.ncbi. nlm.nih.gov/projects/GeneRIF/, within two experimental methodologies (See Fig.2 ): i) Intercellular and ii) Intracellular. There are 3 aspects reported: i) global network statistics, ii) problem specific intercellular results, and iii) problem specific intracellular results. First, the global statistics for the 3 networks (KEGG, Reactome and GeneRIF) are reported in Table 1 for the 3 collection time points. As can be seen, all networks are increasing in size with a very high rate per day both in terms of number of molecules and in terms of number of new interactions. This indicates that, if a system wide analysis is desired, some form of automated approach is needed to aid an investigator. A few molecules in Table 2 have large betweenness centrality values and since natural systems are robust due to, for example, duplication of pathways, these may not necessarily be the most influential molecules. Second, the results for the intercelluar analysis in Table 3 attempt to answer the question: "Which protein interaction will disrupt the cellular contacts and communication between two cells?". High scoring interactions included the ALCAM-CD6 and ITGB1, which dimerizes with integrin alpha-4 to form VLA4 adhesion molecule. It has been recently shown that ALCAM is upregulated in multiple sclerosis patients, disrupting ALCAM-CD6 interaction with a therapeutic antibody inhibited T-cell interaction with brain cells and significantly reducing the severity and delayed the time of onset of multiple sclerosis in an animal model [10] . In addition, Natalizumab is a drug that targets VLA4 and is currently being used in clinics for the treatment of multiple sclerosis. More specifically, it inhibits VLA4 on T-cells from binding blood brain barrier and entering/damaging the brain. Furthermore, the proteins IR1, IR2, IR4, IR5 and IR10 have been associated in the literature [6] with multiple sclerosis, Alzheimer's disease and/or stroke. They are being further validated and
